BDR-WM TRIAL

This home page is related to the ongoing EMN sponsored trial:

A Phase II Study of Combination Bortezomib, Dexamethasone, and Rituximab (BDR) in previously untreated Patients with Waldenstrom's Macroglobulinemia: A multicenter Trial of the European Myeloma Network (EMN).

News

Minutes from the teleconference 20/11/2007 online

Please finde the minutes from the teleconference 20/11/2007 at the intranet part of this web page. Click at the 'log in' link in the left navigation menu.

19 Dec 2007 by BDR-WM Trial

The BDR WM trial web page is online

The home page is related to the ongoing EMN sponsored trial:

A Phase II Study of Combination Bortezomib, Dexamethasone, and Rituximab (BDR) in previously untreated Patients with Waldenstrom's Macroglobulinemia: A multicenter Trial of the European Myeloma Network (EMN).

21 Sep 2007 by BDR-WM Trial

Publications about WM

Pub 1:
WM, Am. J. Hematology, 2003

Pub 2:
WM, Blood, 2007

Pub 3:
WM, Lancet Oncol., 2003

Pub 4:
WM, Clin Lymphoma Meyloma, 2006

Pub 5:
WM, Br J Haematol, 2007

Slides

Slide 1:
Phase II Study of Combination Bortezomib Dexamethasone

BDR-WM TRIAL
Last Update: 21st September 2007